PerkinElmer, Inc. (PKI) (Jobs) to Expand Genetic Screening Business Through Acquisition of ViaCell, Inc. (VIAC); Approximately $300 Million  
10/1/2007 11:10:36 PM

WALTHAM, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, and ViaCell, Inc. (Nasdaq: VIAC), a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells, announced today the signing of a definitive agreement under which PerkinElmer plans to acquire ViaCell. The addition of ViaCell’s ViaCord® product offering for the preservation of umbilical cord blood and its highly qualified sales and marketing organization are expected to significantly expand PerkinElmer’s offerings and reach in neonatal and prenatal markets.